Making motes intelligent:an agent-based approach to wireless sensor networks

In-Motes is a mobile agent middleware that generates an intelligent framework for deploying applications in Wireless Sensor Networks (WSNs). In-Motes is based on the injection of mobile agents into the network that can migrate or clone following specific rules and performing application specific tasks. By doing so, each mote is given a certain degree of perception, cognition and control, forming the basis for its intelligence. Our middleware incorporates technologies such as Linda-like tuplespaces and federated system architecture in order to obtain a high degree of collaboration and coordination for the agent society. A set of behavioral rules inspired by a community of bacterial strains is also generated as the means for robustness of the WSN. In this paper, we present In-Motes and provide a detailed evaluation of its implementation for MICA2 motes.

In-Motes Bins:a real time application for environmental monitoring in wireless sensor networks

In-Motes Bins is an agent based real time In-Motes application developed for sensing light and temperature variations in an environment. In-Motes is a mobile agent middleware that facilitates the rapid deployment of adaptive applications in Wireless Sensor Networks (WSN's). In-Motes Bins is based on the injection of mobile agents into the WSN that can migrate or clone following specific rules and performing application specific tasks. Using In-Motes we were able to create and rapidly deploy our application on a WSN consisting of 10 MICA2 motes. Our application was tested in a wine store for a period of four months. In this paper we present the In-Motes Bins application and provide a detailed evaluation of its implementation. © 2007 IEEE.

Formulation of immunomodulatory agents

Reversed-phase high-performance liquid chromatography procedures were developed for the analysis of pyrimidine-based drugs bropirimine and its derivatives (2-N-acetyl- and 2-N-propanoyl-) and for pyrimethamine and its 2/4- substituted derivatives (2, N-propanoyl and 2,4-N, N-dipropanoyl-) and its 6- substituted (methyl-, ethyl-, propyl- and isopropyl- carboxylates) analogues. Stability studies indicated that these derivatives were not sufficiently labile to act as potential prodrugs. Solubility-pH profiles were constructed from which the dissociation constants were calculated. The physicochemical properties of these compounds were studied and attempts were made to increase the poor aqueous solubility of bropirimine (35μg/mL) by prodrug synthesis, solvate formation (acetic acid, N, N-dimethylformamide and N-methylformamide) and the use of co-solvents and additives. The first two methods proved to be fruitless whereas the latter method resulted in an intravenous formulation incorporating 32mg/mL of bropirimine. An in-vitro method for the detection of precipitation was developed and the results suggested that by using low injection rates (< 0.24mL/min) and high mobile phase flow rates (> 500mL/hr) precipitation could be minimised. Differential scanning calorimetry showed that bropirimine debrominates in the presence of a number of additives commonly used in formulation work but the temperature at which this occurred were usually > 200oC. In-vitro work gave encouraging results for the possibility of rectal delivery of bropirimine but in-vivo work on rabbits showed considerable variations in the resulting plasma levels and pharmacokinetic parameters.